Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Microvisk introduces unique handheld device which monitors blood clotting status

Microvisk Technologies has introduced its unique handheld devices which monitor the blood clotting status of patients to the US market. Showcased at the prestigious American Association for Clinical Chemistry annual conference, the Microvisk devices attracted strong interest from distributors and potential partners ahead of clinical trials in major US medical centres this autumn and product launches in 2012.

31 Aug 2011

New research advances field of plastic-based flexible electronics

New research from Wake Forest University has advanced the field of plastic-based flexible electronics by developing, for the first time, an extremely large molecule that is stable, possesses excellent electrical properties, and inexpensive to produce.

30 Aug 2011

BioAmber selects Sarnia as location for first North American biosuccinic acid plant

BioAmber Inc., through its subsidiary Bluewater Biochemicals has selected Sarnia, Ontario, Canada as the location for its first North American biosuccinic acid plant. The Sarnia plant will have an initial capacity of 17,000 MT and will be commissioned in 2013. Permitting work for the plant was initiated in June 2011. BioAmber currently produces and sells biobased succinic acid at a 3,000 MT capacity plant in France.

29 Aug 2011

SQI Diagnostics third quarter net loss increases to $2,691,000

SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.

29 Aug 2011

Neurotechnology's SentiSight 3.0 SDK now available for universal object recognition

Neurotechnology, a provider of high-precision biometric and object identification technologies, today announced the availability of SentiSight 3.0, a Software Development Kit (SDK) for universal object recognition.

29 Aug 2011

CIRM approves stem cell research planning grants for five UC Davis teams

The California Institute for Regenerative Medicine (CIRM), the state stem cell agency, today approved research planning grants for five UC Davis Health System teams that are working to develop human clinical trials to treat illnesses such as Huntington's disease, vascular disease, osteoporosis, HIV/AIDS and airway disease in children.

29 Aug 2011

NeoStem featured on CBS's Eye on New York City

NeoStem, Inc., an international biopharmaceutical company with a focus on cell-based therapeutic development, today announced that the Company was featured on CBS's Eye on New York City on Wednesday evening, August 24, 2011.

26 Aug 2011

European Journal of Heart Failure publishes results of BIOTRONIK Home-CARE clinical study

BIOTRONIK SE & Co. KG, a worldwide leader in manufacturing cardiac medical devices and pioneer of remote patient management solutions, announced today that results of the Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) clinical study were published in the European Journal of Heart Failure.

26 Aug 2011

Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has received the new drug approval from the State Food and Drug Administration for Iremod.

25 Aug 2011

Foreign drug manufacturing, testing raise regulatory and ethical concerns

JAMA discusses "a recent report from the Pew Health Group about the growing risks of substandard and counterfeit medications resulting from the increasing overseas production of pharmaceuticals and their ingredients."

25 Aug 2011

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today reported its results for the first half year of 2011.

25 Aug 2011

Kewaunee Scientific first quarter sales up 5.9% to $26,321,000

Kewaunee Scientific Corporation today reported sales and earnings for its first quarter ended July 31, 2011. Sales for the quarter were $26,321,000, up 5.9% from sales of $24,858,000 in the first quarter last year. Net earnings for the quarter were $22,000, or $0.01 per diluted share, down from net earnings of $657,000, or $0.25 per diluted share, in the first quarter of the prior year.

24 Aug 2011

Par Pharmaceutical enters definitive agreement to acquire Anchen

Par Pharmaceutical Companies, Inc. announced today that it entered into a definitive agreement to acquire Anchen Pharmaceuticals, a privately-held specialty pharmaceutical company focused on developing and commercializing extended release and niche generic products, for $410 million in cash.

24 Aug 2011

Neovasc second quarter revenues decrease 8% to $879,405

Neovasc Inc., today announced financial results for the three and six months ended June 30, 2011.

24 Aug 2011

Nickel nanoparticles activate cellular pathway that contributes to cancer in lung cells

All the excitement about nanotechnology comes down to this: Structures of materials at the scale of billionths of a meter take on unusual properties. Technologists often focus on the happier among these newfound capabilities, but new research by an interdisciplinary team of scientists at Brown University finds that nanoparticles of nickel activate a cellular pathway that contributes to cancer in human lung cells.

24 Aug 2011

GNC agrees to acquire LuckyVitamin.com

GNC Holdings, Inc., a leading global specialty retailer of nutritional products, today announced it has agreed to acquire LuckyVitamin.com, a leading online value-added retailer of a wide range of nationally branded nutritional supplements with a diverse selection of wellness-oriented products.

24 Aug 2011

MedPro Safety Products second quarter net loss decreases to $2.9 million

MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, today reported on several key financial highlights for the second quarter ended June 30, 2011, as well as significant corporate developments.

23 Aug 2011

Santarus, Depomed enter new commercialization agreement for GLUMETZA

Santarus, Inc. and Depomed, Inc. today announced that they have entered into a new commercialization agreement for GLUMETZA (metformin hydrochloride extended release tablets) under which Santarus will assume broad commercial, manufacturing and regulatory responsibilities to replace a promotion agreement that the companies entered into in July 2008.

23 Aug 2011

NovaDel, Rechon enter license and distribution agreement for Zolpimist

NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

23 Aug 2011

IVAX Diagnostics net revenues decrease 0.4% to $4,375,000 for quarter ended June 30, 2011

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended June 30, 2011.

23 Aug 2011

Manufacturing News and Research

Further Reading

Microvisk introduces unique handheld device which monitors blood clotting status

New research advances field of plastic-based flexible electronics

BioAmber selects Sarnia as location for first North American biosuccinic acid plant

SQI Diagnostics third quarter net loss increases to $2,691,000

Neurotechnology's SentiSight 3.0 SDK now available for universal object recognition

CIRM approves stem cell research planning grants for five UC Davis teams

NeoStem featured on CBS's Eye on New York City

European Journal of Heart Failure publishes results of BIOTRONIK Home-CARE clinical study

Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis

Foreign drug manufacturing, testing raise regulatory and ethical concerns

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

Kewaunee Scientific first quarter sales up 5.9% to $26,321,000

Par Pharmaceutical enters definitive agreement to acquire Anchen

Neovasc second quarter revenues decrease 8% to $879,405

Nickel nanoparticles activate cellular pathway that contributes to cancer in lung cells

GNC agrees to acquire LuckyVitamin.com

MedPro Safety Products second quarter net loss decreases to $2.9 million

Santarus, Depomed enter new commercialization agreement for GLUMETZA

NovaDel, Rechon enter license and distribution agreement for Zolpimist

IVAX Diagnostics net revenues decrease 0.4% to $4,375,000 for quarter ended June 30, 2011

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy